As of 3:59pm ET
| -1.68 / -1.91%|
The 6 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 108.00, with a high estimate of 115.00 and a low estimate of 90.00. The median estimate represents a +24.93% increase from the last price of 86.45.
The current consensus among 7 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.